Lipid abnormalities in pre-eclampsia:implications for vascular health

Bibliography

• Roberts JM, Redman CW: Pre-eclampsia: more than pregnancy-induced hypertension. Lancet 341(8858), 1447–1451 (1993)
   Google Scholar
• Gifford RW, August PA, Cunningham G et al.: Report of the National High Blood Pressure Education Program Working Group on high blood pressure in pregnancy. Am. J. Obstet. Gynecol. 183(Suppl.), 1–22 (2000)
   Google Scholar
• Haukkamaa L, Salminen M, Laivuori H, Leinonen H, Hiilesmaa V, Kaaja R: Risk for subsequent coronary artery disease after pre-eclampsia. Am. J. Cardiol. 93(6), 805–808 (2004)
   Google Scholar
• Rodie VA, Freeman DJ, Sattar N, Greer IA: Pre-eclampsia and cardiovascular disease: metabolic syndrome of pregnancy? Atherosclerosis 174, 189–202 (2004)
   Google Scholar
• Bellamy L, Casas J-P, Hingorani AD, Williams D: Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis. BMJ 335, 974 (2007)
   Google Scholar
• Meta-analysis that synthesizes the knowledge on the long-term consequences of pre-eclampsia
   Google Scholar
• Libby G, Murphy DJ, McEwan NF et al.: Pre-eclampsia and the later development of Type 2 diabetes in mothers and their children: an intergenerational study from the Walker cohort. Diabetologia 50(3), 523–530 (2007)
   Google Scholar
• Tenhola S, Rahiala E, Halonen P, Vanninen E, Voutilainen R: Maternal pre-eclampsia predicts elevated blood pressure in 12-year-old children: evaluation by ambulatory blood pressure monitoring. Pediatr. Res. 59(2), 320–324 (2011)
   Google Scholar
• Vatten LJ, Romundstad PR, Holmen TL, Hsieh CC, Trichopoulos D, Stuver SO: Intrauterine exposure to pre-eclampsia and adolescent blood pressure, body size, and age at menarche in female offspring. Obstet. Gynecol. 101(3), 529–533 (2003)
   Google Scholar
• Kaaja R, Tikkanen MJ, Viinikka L, Ylikorkala O: Serum lipoproteins, insulin, and urinary prostanoid metabolites in normal and hypertensive pregnant women. Obstet. Gynecol. 85, 353–356 (1995)
   Google Scholar
• Kaaja R, Laivuori H, Laakso M, Tikkanen MJ, Ylikorkala O: Evidence of a state of increased insulin resistance in preeclampsia. Metabolism 48, 892–896 (1999)
   Google Scholar
• Magnussen EB, Vatten LJ, Lund-Nilsen TI, Salvesen KA, Smith GD, Romundstad PR: Prepregnancy cardiovascular risk factors as predictors of pre-eclampsia: population based cohort study. BMJ 335, 978 (2007)
   Google Scholar
• Laivuori H, Tikkanen MJ, Ylikorkala O: Hyperinsulinemia 17 years after preeclamptic first pregnancy. J. Clin. Endocrinol. Metab. 81(8), 2908–2911 (1996)
   Google Scholar
• Herrera E: Lipid metabolism in pregnancy and its consequences in the fetus and newborn. Endocrine 19, 43–55 (2002)
   Google Scholar
• Comprehensive study of lipid metabolism in normal pregnancy
   Google Scholar
• Seely EW, Solomon CG: Insulin resistance and its potential role in pregnancy-induced hypertension J. Clin. Endocrinol. Metab. 88(6), 2393–2398 (2003)
   Google Scholar
• Alvarez JJ, Montelongo A, Iglesias A, Lasuncion MA, Herrera E: Longitudinal study on lipoprotein profile, high density lipoprotein subclass, and postheparin lipases during gestation in women. J. Lipid Res. 37, 299–308 (1996)
   Google Scholar
• Griffin BA, Freeman DJ, Tait GW et al.: Role of plasma triglyceride in the regulation of plasma low density protein (LDL) subfractions: relative contribution of small, dense LDL to coronary heart disease risk. Atherosclerosis 106, 241–253 (1994)
   Google Scholar
• Iglesias A, Montelongo A, Herrera E, Lasuncion MA: Changes in cholesterol ester transfer protein activity during normal gestation and postpartum. Clin. Biochem. 27, 63–68 (1994)
   Google Scholar
• Sattar N, Greer IA, Louden J et al.: Lipoprotein subfraction changes in normal pregnancy: threshold effect of plasma triglyceride on appearance of small, dense low density lipoprotein. J. Clin. Endocrinol. Metab. 82, 2483–2491 (1997)
   Google Scholar
• Catalano P, Tyzbir E, Wolfe R, Roman N, Amini S, Sims E: Longitudinal changes in basal hepatic glucose production and suppression during insulin infusion in normal pregnant women. Am. J. Obstet. Gynecol. 167(4 Pt 1), 913–919 (1992)
   Google Scholar
• Catalano P: Carbohydrate metabolism and gestational diabetes. Clin. Obstet. Gynecol. 37, 25–38 (1994)
   Google Scholar
• Ryan E, O’Sullivan M, Skyler J: Insulin action during pregnancy: studies with the euglycemic clamp technique. Diabetes 34, 380–389 (1985)
   Google Scholar
• Buchanan T, Metzger B, Freinkel N, Bergman R: Insulin sensitivity and B-cell responsiveness to glucose during late pregnancy in lean and moderately obese women with normal glucose tolerance or mild gestational diabetes. Am. J. Obstet. Gynecol. 162, 1008–1014 (1990)
   Google Scholar
• Catalano P, Tyzbir E, Roman N, Amini S, Sims E: Longitudinal changes in insulin release and insulin resistance in non-obese pregnant women. Am. J. Obstet. Gynecol. 165, 1667–1772 (1991)
   Google Scholar
• One of the first well-conducted studies demonstrating physiological insulin resistance during the second half of pregnancy
   Google Scholar
• Sivan E, Homko C, Whittaker P, Reece E, Chen X, Boden G: Free fatty acids and insulin resistance during pregnancy. J. Clin. Endocrinol. Metab. 83, 2338–2342 (1998)
   Google Scholar
• Hawkins M, Barzilai N, Liu R, Hu M, Chen W, Rossetti L: Role of glucosamine pathway in fat-induced insulin resistance. J. Clin. Invest. 99, 2173–2182 (1997)
   Google Scholar
• Ryan E, Enns L: Role of gestational hormones in the induction of insulin resistance. J. Clin. Endocrinol. Metab. 67, 341–347 (1988)
   Google Scholar
• Williams C, Coltart T: Adipose tissue metabolism in pregnancy: the lipolytic effect of human placental lactogen. Br. J. Obstet. Gynaecol. 85, 43–46 (1978)
   Google Scholar
• Ray JG, Diamond P, Singh G, Bell CM: Brief overview of maternal triglycerides as a risk factor for pre-eclampsia. Br. J. Obstet. Gynaecol. 113, 379–386 (2011)
   Google Scholar
• Sattar N, Bendomir A, Berry C, Shepherd J, Greer IA, Packard CJ: Lipoprotein subfraction concentrations in preeclampsia: pathogenic parallels to atherosclerosis. Obstet. Gynecol. 89(3), 403–408 (1997)
   Google Scholar
• Schneider JG, von Eynatten M, Schiekofer S, Nawroth PP, Dugi KA: Low plasma adiponectine levels are associated with increased hepatic lipase activity in vivo. Diabetes Care 28, 2181–2186 (2005)
   Google Scholar
• Lorentzen B, Endresen MJ, Clausen T, Henriksen T: Fasting serum free fatty acids and triglycerides are increased before 20 weeks of gestation in women who later develop preeclampsia. Hypertens. Pregnancy 13, 103–109 (1994)
   Google Scholar
• Hubel CA, McLaughlin MK, Evans RW, Hauth BA, Sims CJ, Roberts JM: Fasting serum triglycerides, free fatty acids, and malondialdehyde are increased in preeclampsia, are positively correlated, and decrease within 48 hours post partum. Am. J. Obstet. Gynecol. 174(3), 975–982 (1996)
   Google Scholar
• Murai JT, Muzykanskiy E, Taylor RN: Maternal and fetal modulators of lipid metabolism correlate with the development of preeclampsia. Metabolism 46(8), 963–967 (1997)
   Google Scholar
• Schobel HP, Fischer T, Heuszer K, Geiger H, Schmieder RE: Preeclampsia – a state of sympathetic overactivity. N. Engl. J. Med. 335(20), 1480–1485 (1996)
   Google Scholar
• Kaaja RJ, Moore MP, Yandle TG, Ylikorkala O, Frampton CM, Nicholls MG: Blood pressure and vasoactive hormones in mild preeclampsia and normal pregnancy. Hypertens. Pregnancy 18(2), 173–187 (1999)
   Google Scholar
• Endresen MJ, Lorentzen B, Henriksen T: Increased lipolytic activity and high ratio of free fatty acids to albumin in sera from women with preeclampsia leads to triglyceride accumulation in cultured endothelial cells. Am. J. Obstet. Gynecol. 167(2), 440–447 (1992)
   Google Scholar
• Sattar N, Gaw A, Packard CJ, Greer IA: Potential pathogenic roles of aberrant lipoprotein and fatty acid metabolism in pre-eclampsia. Br. J. Obstet. Gynaecol. 103(7), 614–620 (1996)
   Google Scholar
• Jarvie E, Hauguel-de-Mouzon S, Nelson SM, Sattar N, Catalano PM, Freeman DJ: Lipotoxicity in obese pregnancy and its potential role in adverse pregnancy outcome and obesity in the offspring. Clin. Sci. (Lond.) 119(3), 123–129 (2010)
   Google Scholar
• Shankar SS, Steinberg HO: FFAs: do they play a role in vascular disease in the insulin resistance syndrome? Curr. Diab. Rep. 5(1), 30–35 (2005)
   Google Scholar
• Muniyappa R, Iantorno M, Quon MJ: An integrated view of insulin resistance and endothelial dysfunction. Endocrinol. Metab. Clin. North Am. 37(3), 685–711 (2008)
   Google Scholar
• Pomerantz KB, Hajjar DP: High density lipoprotein induced cholesterol efflux from arterial smooth muscle cell derived foam cells: functional relationship of the cholesteryl ester cycle and eicosanoid biosynthesis. Biochemistry 29, 1892–1899 (1990)
   Google Scholar
• Vi’als M, MartÃnez-GonzÅlez J, Badimon JJ, Badimon L: HDL-induced prostacyclin release in smooth muscle cells is dependent on cyclooxygenase-2 (COX-2). Arterioscler. Thromb. Vasc. Biol. 17, 3481–3488 (1997)
   Google Scholar
• Villa PM, Laivuori H, Kajantie E, Kaaja R: Free fatty acid profiles in preeclampsia. Prostaglandins Leukot. Essent. Fatty Acids 81(1), 17–21 (2011)
   Google Scholar
• Endresen MJ, TÃsti E, Heimli H, Lorentzen B, Henriksen T: Effects of free fatty acids found increased in women who develop pre-eclampsia on the ability of endothelial cells to produce prostacyclin, cGMP and inhibit platelet aggregation. Scand. J. Clin. Lab. Invest. 54(7), 549–557 (1994)
   Google Scholar
• One of the first and classic studies showing the harm of free fatty acids in pre-eclampsia
   Google Scholar
• Wang XL, Zhang L, Youker K et al.: Free fatty acids inhibit insulin signaling-stimulated endothelial nitric oxide synthase activation through upregulating PTEN or inhibiting Akt kinase. Diabetes 55(8), 2301–2310 (2011)
   Google Scholar
• Baker AM, Klein RL, Moss KL, Haeri S, Boggess K: Maternal serum dyslipidemia occurs early in pregnancy in women with mild but not severe preeclampsia. Am. J. Obstet. Gynecol. 201(3), 293.E1–E4 (2011)
   Google Scholar
• Sep S, Verbeek J, Koek G, Smits L, Spaanderman M, Peeters L: Clinical differences between early-onset HELLP syndrome and early-onset preeclampsia during pregnancy and at least 6 months postpartum. Am. J. Obstet. Gynecol. 202(3), 271.E1–E5 (2010)
   Google Scholar
• Clausen T, Djurovic S, Henriksen T: Dyslipidemia in early second trimester is mainly a feature of women with early onset pre-eclampsia. Br. J. Obstet. Gynaecol. 108(10), 1081–1087 (2001)
   Google Scholar
• Enquobahrie DA, Williams MA, Butler CL, Frederick IO, Miller RS, Luthy DA: Maternal plasma lipid concentrations in early pregnancy and risk of preeclampsia. Am. J. Hypertens. 17(7), 574–581 (2004)
   Google Scholar
• Ray JG, Diamond P, Singh G, Bell CM: Brief overview of maternal triglycerides as a risk factor for pre-eclampsia. Br. J. Obstet. Gynaecol. 113(4), 379–386 (2011)
   Google Scholar
• Qiu C, Coughlin KB, Frederick IO, Sorensen TK, Williams MA: Dietary fiber intake in early pregnancy and risk of subsequent preeclampsia. Am. J. Hypertens. 21(8), 903–909 (2008)
   Google Scholar
• Brantsaeter AL, Haugen M, Samuelsen SO et al.: A dietary pattern characterized by high intake of vegetables, fruits, and vegetable oils is associated with reduced risk of preeclampsia in nulliparous pregnant Norwegian women. J. Nutr. 139(6), 1162–1168 (2011)
   Google Scholar
• Straznicky NE, Lambert EA, Lambert GW et al.: Effects of dietary weight loss on sympathetic activity and cardiac risk factors associated with the metabolic syndrome. J. Clin. Endocrinol. Metab. 90, 5998–6005 (2005)
   Google Scholar
• Blumenthal JA, Babyak MA, Sherwood AL et al.: Effects of the dietary approaches to stop hypertension diet alone and in combination with exercise and caloric restriction on insulin sensitivity and lipids. Hypertension 55(5), 1199–1205 (2010)
   Google Scholar
• Portelinha A, Belo L, Cerdeira AS et al.: Lipid levels including oxidized LDL in women with history of preeclampsia. Hypertens. Pregnancy 29(1), 93–100 (2010)
   Google Scholar
• Hubel CA, Snaedal S, Ness RB et al.: Dyslipoproteinaemia in postmenopausal women with a history of eclampsia. Br. J. Obstet. Gynaecol. 107(6), 776–784 (2000)
   Google Scholar
• Lampinen KH, Rönnback M, Groop PH, Kaaja RJ: A relationship between insulin sensitivity and vasodilation in women with a history of preeclamptic pregnancy. Hypertension 52(2), 394–401 (2008)
   Google Scholar
• De Groot E, Hovingh GK, Wiegman A et al.: Measurement of arterial wall thickness as a surrogate marker for atherosclerosis. Circulation 109(Suppl. 1), III33– III38 (2004)
   Google Scholar
• Haukkamaa L, Moilanen L, Kattainen A et al.: Pre-eclampsia is a risk factor of carotid artery atherosclerosis. Cerebrovasc. Dis. 27(6), 599–607 (2011)
   Google Scholar
• Bernard N, Girouard J, Forest JC, Giguère Y: The combination of apoCIII, hepatic lipase and hormono sensitive lipase gene polymorphisms suggests an association with susceptibility to gestational hypertension. J. Hum. Genet. 52(3), 244–254 (2007)
   Google Scholar
• Kim YJ, Williamson RA, Chen K, Smith JL, Murray JC, Merrill DC: Lipoprotein lipase gene mutations and the genetic susceptibility of preeclampsia. Hypertension 38(5), 992–996 (2001)
   Google Scholar
• Enquobahrie DA, Sanchez SE, Muy?Rivera M et al.: Hepatic lipase gene polymorphism, pre-pregnancy overweight status and risk of preeclampsia among Peruvian women. Gynecol. Endocrinol. 21(4), 211–217 (2005)
   Google Scholar
• Costantine MM, Tamayo E, Lu F et al.: Using pravastatin to improve the vascular reactivity in a mouse model of soluble Fms-like tyrosine kinase-1-induced preeclampsia. Obstet. Gynecol. 116, 114–120 (2010).
   Google Scholar